This inventor holds 1 USPTO granted patent. Top assignees: Mpi Corporation, Other. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 152 
1 out of 834,513 Years Active: 1994
Title: Tetsuya Matsuno: Innovator in Antitumor Drug Development
Introduction
Tetsuya Matsuno is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor drugs. His innovative work has garnered attention for its potential impact on cancer treatment.
Latest Patents
Matsuno holds a patent for a novel physiologically active substance, which is represented by a specific formula. This substance is preferably derived from propolis and exhibits excellent antitumor activity, making it a valuable candidate for use as an antitumor drug. His patent is a testament to his dedication to advancing medical science.
Career Highlights
Throughout his career, Tetsuya Matsuno has worked with Mpi Corporation, where he has been involved in groundbreaking research and development. His work has focused on creating effective treatments that can improve patient outcomes in the fight against cancer.
Collaborations
Matsuno has collaborated with several professionals in his field, including Mayumi Yoshida and Yutaka Saito. These partnerships have contributed to the success of his projects and the advancement of innovative solutions in healthcare.
Conclusion
Tetsuya Matsuno's contributions to the development of antitumor drugs highlight his role as an influential inventor in the pharmaceutical industry. His work continues to inspire advancements in cancer treatment and showcases the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile